Drug Houses of Australia was an Australian public company established in 1936 as an amalgamation of seven Australian pharmaceutical companies, including Felton Grimwade & Co and A. M. Bickford & Sons. In 1970, DHA was taken over by the British bank Slater Walker.
In September 2006, the Australian company was sold to Strides Arcolab through a share purchase agreement with Haw Par Healthcare Limited, Singapore, for approximately SGD$19.7 million. Drug Houses of Australia (Asia) Pte Ltd is now a leading manufacturer of generic pharmaceutics and Chinese proprietary medicine (CPM) based in Jurong, Singapore; and is a subsidiary of Strides Arcolab that is listed on both the Bombay and National stock exchanges in India.
References
External links
Strides Arcolab website Haw Par website